Target intelligence / Profile preview

Neuroligin 4, Y-linked (NLGN4Y)

Target
NLGN4Y
Molecular classification
Cell adhesion molecule, Synaptic adhesion protein, Other
01

Overview

Neuroligin 4, Y-linked (NLGN4Y) is a type I membrane protein and member of the neuroligin family, which are cell adhesion molecules located at the postsynaptic side of the synapse and are important in the formation of functional synapses in the nervous system[1][3]. The protein is encoded by a gene on the Y chromosome, making it male-specific. Its X-linked paralog is NLGN4X. NLGN4Y plays a role in synaptic organization, cell-cell interactions through neurexin binding, and neural development. Rare sequence variants or haplotypes of NLGN4Y may modestly contribute to neurodevelopmental disorders such as autism spectrum disorder, particularly influencing male-specific risk[1][2]. Increases in NLGN4Y gene copy number and expression have also been linked to autism-related social deficits among boys with XYY syndrome[1]. Outside the nervous system, reduced expression of NLGN4Y has been linked to more aggressive prostate cancer, while experimental restoration of its expression suppresses cell proliferation and migration, suggesting a tumor-suppressive function[1]. NLGN4Y has also gained attention in research on male sexual orientation: elevated maternal antibodies to NLGN4Y have been associated with altered brain development related to sexual orientation in male offspring, supporting a maternal immune hypothesis[2]. No approved drugs are currently known to interact with NLGN4Y, nor is it a recognized therapeutic target in clinical practice. As a synaptic adhesion molecule, its biological functions are primarily related to neural connectivity and synaptic function rather than direct druggability[1][3].

Other names
Neuroligin-4, Y-linkedNLGN4YKIAA0951Neuroligin YHNL4Y
02

Biological functions

Synaptic adhesionFormation of functional synapsesCell-cell interaction
03

Disease associations

Neurodevelopmental diseaseCancer (specifically prostate cancer)Other
04

Safety considerations

Potential implications in neurodevelopmental disorders and prostate cancer progression, but no direct therapeutic targeting or major clinical safety concerns identified
05

Biomarkers

Anti-NLGN4Y antibody (in context of maternal immune response and sexual orientation research)

Beyond the preview

Go deeper on Neuroligin 4, Y-linked (NLGN4Y).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroligin 4, Y-linked (NLGN4Y).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call